Compare GXO & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GXO | MMSI |
|---|---|---|
| Founded | 2021 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.9B |
| IPO Year | N/A | 1990 |
| Metric | GXO | MMSI |
|---|---|---|
| Price | $56.71 | $83.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 8 |
| Target Price | $64.17 | ★ $106.13 |
| AVG Volume (30 Days) | ★ 957.9K | 739.4K |
| Earning Date | 02-10-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.76 | ★ 1.95 |
| Revenue | ★ $12,921,000,000.00 | $1,477,128,000.00 |
| Revenue This Year | $13.35 | $13.60 |
| Revenue Next Year | $6.10 | $6.23 |
| P/E Ratio | $72.33 | ★ $41.87 |
| Revenue Growth | ★ 16.94 | 11.41 |
| 52 Week Low | $30.46 | $78.12 |
| 52 Week High | $58.00 | $111.45 |
| Indicator | GXO | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 58.51 | 45.31 |
| Support Level | $54.95 | $79.65 |
| Resistance Level | $58.00 | $82.48 |
| Average True Range (ATR) | 1.58 | 3.19 |
| MACD | -0.03 | -0.74 |
| Stochastic Oscillator | 76.89 | 26.69 |
GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.